Metabolic Biomarker Testing Market Research Report Information By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders), Application (Drug Discovery, Nutrigenomics, Toxicology Testing, Personalized Medicine), Technique, End User – Forecast To 2030

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Metabolic Biomarkers Testing Market, by Techniques

6.1 Introduction

6.2 Separation techniques

6.2.1 Market Estimates & Forecast, 2020 – 2023

6.2.2 Liquid Chromatography

6.2.2.1 Market Estimates & Forecast, 2020 – 2023

6.2.2.2 High Performance Liquid Chromatography

6.2.2.2.1 Market Estimates & Forecast, 2020 – 2023

6.2.2.3 Ultra Performance Liquid Chromatography

6.2.2.3.1 Market Estimates & Forecast, 2020 – 2023

6.2.3 Gas Chromatography

6.2.3.1 Market Estimates & Forecast, 2020 – 2023

6.2.4 Capillary Chromatography

6.2.4.1 Market Estimates & Forecast, 2020 – 2023

6.3 Detection techniques

6.3.1 Market Estimates & Forecast, 2020 – 2023

6.3.2 Mass Spectrometry

6.3.2.1 Market Estimates & Forecast, 2020 – 2023

6.3.3 Multivariate Analysis

6.3.3.1 Market Estimates & Forecast, 2020 – 2023

6.3.4 Spectroscopy

6.3.4.1 Market Estimates & Forecast, 2020 – 2023

6.3.4.2 Nuclear Magnetic Resonance Spectroscopy

6.3.4.2.1 Market Estimates & Forecast, 2020 – 2023

6.3.4.3 Fourier Transform Infrared Spectroscopy

6.3.4.3.1 Market Estimates & Forecast, 2020 – 2023

6.4 Others

Chapter 7. Global Metabolic Biomarkers Testing Market, by Indications

7.1 Introduction

7.2 Cancer

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Cardiovascular disorders,

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Neurological disorders

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Inborn errors of metabolism

7.5.1 Market Estimates & Forecast, 2020-2027

7.6 Others

Chapter 8. Global Metabolic Biomarkers Testing Market, by Application

8.1 Introduction

8.2 Drug discovery

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Nutrigenomics

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Toxicology testing

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Personalized medicine

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Functional genomics

8.6.1 Market Estimates & Forecast, 2020-2027

8.7 Others

Chapter 9. Global Metabolic Biomarkers Testing Market, by End Users

9.1 Introduction

9.2 Pharma & biotech companies

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Diagnostic tool companies

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Healthcare IT /Big Data Companies

9.4.1 Market Estimates & Forecast, 2020-2027

9.5 Clinical Laboratories

9.5.1 Market Estimates & Forecast, 2020-2027

9.6 Others

Chapter .10 Global Metabolic Biomarkers Testing Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Agilent Technologies, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Bio-Rad Laboratories, Inc

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Bruker Corporation

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Danaher Corporation

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Waters Corporation

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Thermo Fisher Scientific, Inc

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Thermo Fisher Scientific, Inc

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Biocrates Life Sciences AG.

12.8.1 Company Overview

12.8.2 Product/Business Segment Overview

12.8.3 Financial Overview

12.8.4 Key Development

12.8.5 SWOT Analysis

12.9 Human Metabolome Technologies Inc.

12.9.1 Company Overview

12.9.2 Product Overview

12.9.3 Financial overview

12.9.4 Key Developments

12.10 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Metabolic Biomarkers Testing Application Industry Synopsis, 2020-2027

Table 2 Metabolic Biomarkers Testing Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Metabolic Biomarkers Testing Market by Region, 2020-2027, (USD Million)

Table 4 Metabolic Biomarkers Testing Market by Techniques, 2020-2027, (USD Million)

Table 5 Metabolic Biomarkers Testing Market by Application, 2020-2027, (USD Million)

Table 6 Metabolic Biomarkers Testing Market by End Users, 2020-2027, (USD Million)

Table 7 North America Metabolic Biomarkers Testing Market by Techniques, 2020-2027, (USD Million)

Table 8 North America Metabolic Biomarkers Testing Market by Application, 2020-2027, (USD Million)

Table 9 North America Metabolic Biomarkers Testing Market by End Users, 2020-2027, (USD Million)

Table 10 US Metabolic Biomarkers Testing Market by Techniques, 2020-2027, (USD Million)

Table 11 US Metabolic Biomarkers Testing Market by Application, 2020-2027, (USD Million)

Table 12 US Metabolic Biomarkers Testing Market by End Users, 2020-2027, (USD Million)

Table 13 Canada Metabolic Biomarkers Testing Market by Techniques, 2020-2027, (USD Million)

Table 14 Canada Metabolic Biomarkers Testing Market by Application, 2020-2027, (USD Million)

Table 15 Canada Metabolic Biomarkers Testing Market by End Users, 2020-2027, (USD Million)

Table 16 South America Metabolic Biomarkers Testing Market by Techniques, 2020-2027, (USD Million)

Table 17 South America Metabolic Biomarkers Testing Market by Application, 2020-2027, (USD Million)

Table 18 South America Metabolic Biomarkers Testing Market by End Users, 2020-2027, (USD Million)

Table 19 Europe Metabolic Biomarkers Testing Market by Techniques, 2020-2027, (USD Million)

Table 20 Europe Metabolic Biomarkers Testing Market by Application, 2020-2027, (USD Million)

Table 21 Europe Metabolic Biomarkers Testing Market by End Users, 2020-2027, (USD Million)

Table 22 Western Europe Metabolic Biomarkers Testing Market by Techniques, 2020-2027, (USD Million)

Table 23 Western Europe Metabolic Biomarkers Testing Market by Application, 2020-2027, (USD Million)

Table 24 Western Europe Metabolic Biomarkers Testing Market by End Users, 2020-2027, (USD Million)

Table 25 Eastern Europe Metabolic Biomarkers Testing Market by Techniques, 2020-2027, (USD Million)

Table 26 Eastern Europe Metabolic Biomarkers Testing Market by Application, 2020-2027, (USD Million)

Table 27 Eastern Europe Metabolic Biomarkers Testing Market by End Users, 2020-2027, (USD Million)

Table 28 Asia Pacific Metabolic Biomarkers Testing Market by Techniques, 2020-2027, (USD Million)

Table 29 Asia Pacific Metabolic Biomarkers Testing Market by Application, 2020-2027, (USD Million)

Table 30 Asia Pacific Metabolic Biomarkers Testing Market by End Users, 2020-2027, (USD Million)

Table 31 Middle East & Africa Metabolic Biomarkers Testing Market by Techniques, 2020-2027, (USD Million)

Table 32 Middle East & Africa Metabolic Biomarkers Testing Market by Application, 2020-2027, (USD Million)

Table 33 Middle East & Africa Metabolic Biomarkers Testing Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Metabolic Biomarkers Testing Market

Figure 3 Segmentation Market Dynamics for Metabolic Biomarkers Testing Market

Figure 4 Global Metabolic Biomarkers Testing Market Share, by Techniques 2020

Figure 5 Global Metabolic Biomarkers Testing Market Share, by Application 2020

Figure 6 Global Metabolic Biomarkers Testing Market Share, by End Users, 2020

Figure 7 Global Metabolic Biomarkers Testing Market Share, by Region, 2020

Figure 8 North America Metabolic Biomarkers Testing Market Share, by Country, 2020

Figure 9 Europe Metabolic Biomarkers Testing Market Share, by Country, 2020

Figure 10 Asia Pacific Metabolic Biomarkers Testing Market Share, by Country, 2020

Figure 11 Middle East & Africa Metabolic Biomarkers Testing Market Share, by Country, 2020

Figure 12 Global Metabolic Biomarkers Testing Market: Company Share Analysis, 2020 (%)

Figure 13 Agilent Technologies, Inc.: Key Financials

Figure 14 Agilent Technologies, Inc.: Segmental Revenue

Figure 15 Agilent Technologies, Inc.: Geographical Revenue

Figure 16 Bio-Rad Laboratories, Inc.: Key Financials

Figure 17 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 18 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 19 Bruker Corporation: Key Financials

Figure 20 Bruker Corporation: Segmental Revenue

Figure 21 Bruker Corporation: Geographical Revenue

Figure 22 Danaher Corporation: Key Financials

Figure 23 Danaher Corporation: Segmental Revenue

Figure 24 Danaher Corporation: Geographical Revenue

Figure 25 Waters Corporation: Key Financials

Figure 26 Waters Corporation: Segmental Revenue

Figure 27 Waters Corporation: Geographical Revenue

Figure 28 Thermo Fisher Scientific, Inc.: Key Financials

Figure 29 Thermo Fisher Scientific, Inc.: Segmental Revenue

Figure 30 Thermo Fisher Scientific, Inc.: Geographical Revenue

Figure 31 Thermo Fisher Scientific, Inc.: Key Financials

Figure 32 Thermo Fisher Scientific, Inc.: Segmental Revenue

Figure 33 Thermo Fisher Scientific, Inc.: Geographical Revenue

Figure 34 Biocrates Life Sciences AG: Key Financials

Figure 35 Biocrates Life Sciences AG: Segmental Revenue

Figure 36 Biocrates Life Sciences AG: Geographical Revenue

Figure 37 Human Metabolome Technologies Inc.: Key Financials

Figure 38 Human Metabolome Technologies Inc.: Segmental Revenue

Figure 39 Human Metabolome Technologies Inc.: Geographical Revenue